Studying the Effects of Phentermine on Eating Behavior
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01886937|
Recruitment Status : Completed
First Posted : June 26, 2013
Results First Posted : July 31, 2017
Last Update Posted : July 31, 2017
|Condition or disease||Intervention/treatment||Phase|
|Obesity||Drug: Phentermine Drug: placebo||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||13 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||The Quantification of Ingestive Behavior|
|Study Start Date :||July 2012|
|Actual Primary Completion Date :||June 2014|
|Actual Study Completion Date :||June 2014|
Experimental: 37.5 mg Phentermine daily for 7 days
In this arm, participants receive 37.5mg phentermine for one week followed by 2 weeks of placebo.
Other names for phentermine:
After 7 days of phentermine 37.5 mg administration, food intake should be less than after 14 days of placebo.
Placebo Comparator: Placebo (for phentermine 37.5mg)
In this arm, participants receive Placebo (for 37.5mg phentermine) for two weeks followed by phentermine 37.5mg for 7 days.
Food intake as measured by a laboratory study should be greater after 7 days of placebo administration compared to seven days of phentermine administration.
Other Name: sugar pill
- Food Intake [ Time Frame: one week ]The primary outcome measure is food intake assessed by laboratory meal study after one week of phentermine administration compared to one week of placebo administration.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01886937
|United States, New York|
|The New York State Psychiatric Institute at Columbia University Medical Center|
|New York, New York, United States, 10032|
|Principal Investigator:||Laurel Mayer, MD||Columbia University Medical Center/New York State Psychiatric Institute|